Medifast, Inc.

NYSE:MED

Personal Products & Services

Consumer Cyclical
$12.20 -0.04%

-$0.01 today

Market cap
$136.43M
Beta
0.66
P/E (TTM)
-6.2
EPS (TTM)
-$1.82
52W Low $9.22High $15.46

Volume 0.09M

Average 0.21M

MED Short-term Investments

Marketable securities and deposits the company expects to convert to cash within a year.

Medifast, Inc.NYSE: MED

Short-term Investments · Q1 FY2026 · quarter ended Mar 2026

Short-term investments rises 33.7% from a year ago

Short-term investments stood at $97.42M at the end of Q1 FY2026, up 33.7% from a year earlier and up 24.9% from the prior quarter.

Context

  • Short-term investments amounted to 38.7% of total assets at the end of Q1 FY2026, up 12.6 pp from a year earlier.
  • Short-term investments increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether short-term investments keeps rising in the next quarterly balance sheet after a +33.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$97.42M+24.9% QoQ
Last fiscal yearDec 2025
$77.97M+9.2% YoY
Year agoMar 2025
$72.88M+33.7% since
Short-term Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+33.7%——
1 year+9.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Short-term Investments history

USD · from the balance sheet

Latest · FY2025
77.97M USD
Year-over-year change
+9.2%
4-year CAGR
+95.3%

Short-term Investments vs competitors

How MED compares with its peers on the latest reported figures

  • Peers report in different currencies, so short-term investments is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +33.7% is the highest of 4, against a peer median of -11.8%.
  • Short-term investments amounts to 38.7% of total assets for MED, versus a peer median of 0.0%.
MED Competitors
Short-term Investments for MED and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MEDMedifast, Inc.Mar 2026$97.42M USD+33.7%—38.7%
DIBS1stdibs.Com, Inc.Mar 2026$64.96M USD-19.5%—53.3%
CAASChina Automotive Systems, Inc.Dec 2025$35.93M USD+30.4%+40.8%3.6%
BSETBassett Furniture Industries, IncorporatedFeb 2026$17.96M USD-11.8%+0.5%5.7%
CURVTorrid Holdings Inc.May 2026$0 USD——0.0%
CLARClarus CorporationMar 2026$0 USD——0.0%
KEQUKewaunee Scientific CorporationJan 2026$0 USD——0.0%
AKAa.k.a. Brands Holding Corp.Mar 2026$0 USD——0.0%
MBMasterBeef GroupDec 2025HK$0 HKD——0.0%
AIIORobo.ai Inc.Jun 2025$0 USD——0.0%
Peer median (excluding MED) —-11.8%+20.7%0.0%

Competitors are the stored peer set for MED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents104.18M87.69M94.44M90.93M89.3M
Short-term Investments5.36M055.6M71.42M77.97M
Net Receivables00000
Inventory180.04M118.86M54.59M42.42M20.23M
Other Current Assets16.33M1009.07M
Total Current Assets306.87M222.78M224.03M214.4M201.68M
Property, Plant & Equipment (Net)80.59M75.65M67.11M48.68M38.46M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets4.4M5.33M4.12M11.46M9.04M
Other Non-current Assets6.47M12.46M14.65M9.67M7.83M
Total Non-current Assets91.46M93.43M85.88M69.81M55.33M
Total Assets398.33M316.21M309.91M284.21M257.01M
Account Payables70.89M53.12M39.19M23.05M15.07M
Short-term Debt00004.6M
Tax Payables2.57M7.55M9.86M1.49M5.12M
Deferred Revenue8.05M7.36M574K316K384K
Other Current Liabilities00032.77M13.63M
Total Current Liabilities169.83M140.89M92.3M64.16M42.96M
Long-term Debt00006.09M
Deferred Tax Liabilities00009.04M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0000(6.09M)
Total Non-current Liabilities26.02M20.28M16.13M9.94M15.13M
Total Liabilities195.85M161.17M108.43M74.1M58.09M
Common Stock12K11K11K11K11K
Retained Earnings190.33M139.85M174.65M176.78M158.27M
Accumulated OCI111K24K248K180K234K
Other Stockholders Equity00000
Minority Interest00000
Total Equity202.47M155.04M201.48M210.11M198.92M
Total Debt32.54M26.05M22.01M16.13M16.79M
Net Debt(71.64M)(61.64M)(72.43M)(74.8M)(72.52M)

Medifast, Inc.

NYSE:MED

Intrinsic Alpha fair value

Locked

Current Price

$12.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.